Stocks

Headlines

Cresco Labs Reports Quarterly Loss, Misses Revenue Estimates

Cresco Labs Inc. reported a quarterly loss that exceeded expectations while also missing revenue forecasts. This performance casts uncertainty over the company's future prospects, which may influence investor sentiment and stock prices moving forward.

Date: 
AI Rating:   4

Cresco Labs Inc. (CRLBF) experienced a quarterly loss of $0.02 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.01. The report revealed an earnings surprise of -100%, indicating a significant underperformance compared to expectations. A year ago, the company's loss was $0.04 per share, suggesting a slight improvement but still not favorable.

Furthermore, the previous quarter's expectations were also not met, as Cresco reported an actual loss of $0.16 per share against an estimated loss of $0.01, resulting in a staggering surprise of -1,500%. Over the last four quarters, Cresco Labs has only surpassed consensus EPS estimates once, reflecting an ongoing struggle to meet financial expectations.

Revenue figures for the quarter were reported at $179.78 million, which fell short of the Zacks Consensus Estimate by 2.94%. This revenue represents a decline from the $190.56 million reported in the same quarter a year prior. In the past four quarters, Cresco has managed to top consensus revenue estimates three times, though this latest miss may raise concerns among investors.

The stock's immediate price movement is likely to be influenced by management's commentary during the earnings call. Cresco Labs shares have lost about 5.6% year-to-date, contrasting sharply with the S&P 500's gain of 25.2%, highlighting the firm's underperformance against the broader market.

Looking ahead, investor sentiment may hinge on the company’s earnings outlook and trends in earnings estimate revisions as the market closely watches for potential adjustments. Currently, Cresco holds a Zacks Rank of #3 (Hold), suggesting that the shares are expected to perform in line with the market.

Stocks:  CRLBF